Thoracoscopic surgical ablation

PROCEDURE4 trials

Sponsors

Royal Brompton & Harefield NHS Foundation Trust, China National Center for Cardiovascular Diseases, Guangdong Academy of Medical Sciences, Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

Conditions

Atrial FibrillationHeart DiseasesPersistent Atrial Fibrillation

Phase 3

Thoracoscopic Ablation for Lone Atrial Fibrillation

Federal Research Clinical Center of Federal Medical & Biological Agency, RussiaAtrial Fibrillation, Heart Diseases

Start: 2021-01-06End: 2023-09-30Updated: 2023-02-01

Unknown Phase

Catheter Ablation Versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF)

Royal Brompton & Harefield NHS Foundation TrustPersistent Atrial Fibrillation

Start: 2015-06-30End: 2020-03-31Updated: 2019-09-12

Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial Fibrillation

CompletedNCT03127423

China National Center for Cardiovascular DiseasesPersistent Atrial Fibrillation

Start: 2016-12-31End: 2022-12-31Updated: 2023-04-27

Two-stage Hybrid Ablation or Thoracoscopic Epicardial Ablation for Long-standing Persistent Atrial Fibrillation

Guangdong Academy of Medical SciencesAtrial Fibrillation

Start: 2018-03-04End: 2022-12-31Target: 150Updated: 2020-02-11

Related Papers

Left Atrial Function Predicts Atrial Arrhythmia Recurrence Following Ablation of Long-Standing Persistent Atrial Fibrillation

Circulation Cardiovascular Imaging2023-06-0160 citations

Thoracoscopic surgical ablation versus catheter ablation as first-line treatment for long-standing persistent atrial fibrillation: the CASA-AF RCT

Efficacy and Mechanism Evaluation2021-10-014 citations

Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial

European Heart Journal2020-08-0489 citations